Skip to main content
OGN logo
OGN
(NYSE)
Organon & Co.
$13.75-- (--)
Loading... - Market loading

Organon & Co. (OGN) Stock Price & Financial Analysis

Organon & Co. Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.73 - $13.76
52-Week High$13.72
52-Week Low$5.69
Open$13.74
Volume1.77M
Average Volume (3M)2.55M
Market Cap3.61B
Shares Outstanding262.90M
P/E Ratio (TTM)14.64
Forward P/E29.07
Price to Sales (P/S)0.58
Price to Book (P/B)3.99
EV/EBITDA8.52
Revenue (TTM)6.16B
Net Income (TTM)246.00M
Free Cash Flow (TTM)683.00M
EPS (TTM)$0.94
Profit Margin3.99%
Operating Margin18.72%
Return on Equity (ROE)27.24%
Debt to Equity9.49
50-Day MA$13.52
200-Day MA$9.81
52-Week Change45.13%
Annual Dividend$0.06
Dividend Yield0.44%
Payout Ratio6.37%
Last Dividend Ex-DateMay 11, 2026

Frequently Asked Questions About Organon & Co.

What is the current stock price for OGN?

As of the latest trading session, OGN stock trades at $13.75. The 52-week range is $5.69–$13.72, with a day range of $13.73–$13.76.

What is the P/E ratio for OGN?

Organon & Co.'s trailing P/E ratio is 14.6, meaning investors pay $14.6 for every $1 of annual earnings. The forward P/E is 29.1, reflecting analyst expectations for future earnings. Organon & Co. operates in the Healthcare sector.

Does OGN pay dividends?

Yes, Organon & Co. pays a 0.44% annual dividend yield ($0.06 per share). The payout ratio is 6.4%. The last ex-dividend date was 2026-05-11.

What do analysts recommend for OGN?

Analyst ratings and recommendations for OGN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of OGN?

Organon & Co.'s market capitalization is $3.61B, classifying it as a mid-cap company. Organon & Co. operates in the Healthcare sector within the Drug Manufacturers - General industry.